Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.

Nayak L, Abrey LE, Drappatz J, Gilbert MR, Reardon DA, Wen PY, Prados M, Deangelis LM, Omuro A; North American Brain Tumor Consortium.

Leuk Lymphoma. 2013 Jan;54(1):58-61. doi: 10.3109/10428194.2012.698736. Epub 2012 Jul 9.

2.

Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.

Wong ET, Tishler R, Barron L, Wu JK.

Cancer. 2004 Jul 1;101(1):139-45.

3.

Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.

Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, Treseler P, O'Brien J, Shuman MA, Cha S, Damon LE, Rubenstein JL.

Clin Cancer Res. 2012 Feb 15;18(4):1146-55. doi: 10.1158/1078-0432.CCR-11-0625. Epub 2012 Jan 6.

4.

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.

Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP.

J Clin Oncol. 2016 May 10;34(14):1620-5. doi: 10.1200/JCO.2015.64.8634. Epub 2016 Mar 28.

5.

[Therapeutic management of central nervous system lymphomas in a single hematological institute].

Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.

Orv Hetil. 2009 Oct 18;150(42):1937-44. doi: 10.1556/OH.2009.28703. Hungarian.

PMID:
19812012
6.

High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma.

Masaki Y, Miki M, Sun Y, Nakamura T, Iwao H, Nakajima A, Kurose N, Sakai T, Jin ZX, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Hirose Y, Umehara H.

Int J Hematol. 2011 Jun;93(6):720-6. doi: 10.1007/s12185-011-0848-1. Epub 2011 May 15.

PMID:
21573892
7.

Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.

del Rio MS, Choquet S, Hoang-Xuan K, Glaisner S, Fourme E, Janvier M, Soussain C.

J Neurooncol. 2011 Nov;105(2):409-14. doi: 10.1007/s11060-011-0608-3. Epub 2011 Jun 9.

PMID:
21656329
8.

Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.

Mappa S, Marturano E, Licata G, Frezzato M, Frungillo N, Ilariucci F, Stelitano C, Ferrari A, Sorarù M, Vianello F, Baldini L, Proserpio I, Foppoli M, Assanelli A, Reni M, Caligaris-Cappio F, Ferreri AJ.

Hematol Oncol. 2013 Sep;31(3):143-50. doi: 10.1002/hon.2037. Epub 2012 Nov 14.

PMID:
23161567
9.

Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.

Pitini V, Arrigo C, Righi M.

Cancer. 2004 Dec 15;101(12):2900-1; author reply 2901-2. No abstract available.

10.

Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.

Wang Y, Liu B, Xu D, Zhao H, Zhu Y, Xu J, Tao R.

Neurol India. 2013 May-Jun;61(3):260-4. doi: 10.4103/0028-3886.115065.

11.

Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly.

Fritsch K, Kasenda B, Hader C, Nikkhah G, Prinz M, Haug V, Haug S, Ihorst G, Finke J, Illerhaus G.

Ann Oncol. 2011 Sep;22(9):2080-5. doi: 10.1093/annonc/mdq712. Epub 2011 Feb 8.

PMID:
21303800
12.

Combination therapy with rituximab and temozolomide for recurrent and refractory primary central nervous system lymphoma.

Murakami M, Fujimaki T, Asano S, Nakaguchi H, Yamada SM, Hoya K, Yamazaki K, Ishida Y, Matsuno A.

Yonsei Med J. 2011 Nov;52(6):1031-4. doi: 10.3349/ymj.2011.52.6.1031.

13.

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.

Omuro AM, Taillandier L, Chinot O, Carnin C, Barrie M, Hoang-Xuan K.

J Neurooncol. 2007 Nov;85(2):207-11. Epub 2007 Sep 21.

PMID:
17896079
14.

Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule.

Santisteban M, Nieto Y, De la Cruz S, Aristu J, Zubieta JL, Fernández Hidalgo O.

Clin Transl Oncol. 2007 Jul;9(7):465-7.

PMID:
17652061
15.

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group.

Pulczynski EJ, Kuittinen O, Erlanson M, Hagberg H, Fosså A, Eriksson M, Nordstrøm M, Østenstad B, Fluge Ø, Leppä S, Fiirgaard B, Bersvendsen H, Fagerli UM.

Haematologica. 2015 Apr;100(4):534-40. doi: 10.3324/haematol.2014.108472. Epub 2014 Dec 5.

16.

Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status.

Makino K, Nakamura H, Hide T, Kuratsu J.

J Neurooncol. 2012 Jan;106(1):155-60. doi: 10.1007/s11060-011-0652-z. Epub 2011 Jul 1.

PMID:
21720808
17.

Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.

Ferreri AJ, Reni M, Dell'Oro S, Ciceri F, Bernardi M, Camba L, Ponzoni M, Terreni MR, Tomirotti M, Spina M, Villa E.

Oncology. 2001;60(2):134-40.

PMID:
11244328
18.
19.

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).

Schorb E, Finke J, Ferreri AJ, Ihorst G, Mikesch K, Kasenda B, Fritsch K, Fricker H, Burger E, Grishina O, Valk E, Zucca E, Illerhaus G.

BMC Cancer. 2016 Apr 21;16:282. doi: 10.1186/s12885-016-2311-4.

20.

High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma.

Chamberlain MC, Johnston SK.

Neuro Oncol. 2010 Jul;12(7):736-44. doi: 10.1093/neuonc/noq011. Epub 2010 Feb 8.

Supplemental Content

Support Center